Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Regul Toxicol Pharmacol ; 47(2): 115-35, 2007 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-17207562

RESUMO

A weight of evidence (WOE) reproductive and developmental toxicology (reprotox) database was constructed that is suitable for quantitative structure-activity relationship (QSAR) modeling and human hazard identification of untested chemicals. The database was derived from multiple publicly available reprotox databases and consists of more than 10,000 individual rat, mouse, or rabbit reprotox tests linked to 2134 different organic chemical structures. The reprotox data were classified into seven general classes (male reproductive toxicity, female reproductive toxicity, fetal dysmorphogenesis, functional toxicity, mortality, growth, and newborn behavioral toxicity), and 90 specific categories as defined in the source reprotox databases. Each specific category contained over 500 chemicals, but the percentage of active chemicals was low, generally only 0.1-10%. The mathematical WOE model placed greater significance on confirmatory observations from repeat experiments, chemicals with multiple findings within a category, and the categorical relatedness of the findings. Using the weighted activity scores, statistical analyses were performed for specific data sets to identify clusters of categories that were correlated, containing similar profiles of active and inactive chemicals. The analysis revealed clusters of specific categories that contained chemicals that were active in two or more mammalian species (trans-species). Such chemicals are considered to have the highest potential risk to humans. In contrast, some specific categories exhibited only single species-specific activities. Results also showed that the rat and mouse were more susceptible to dysmorphogenesis than rabbits (6.1- and 3.6-fold, respectively).


Assuntos
Anormalidades Induzidas por Medicamentos , Bases de Dados Factuais , Modelos Teóricos , Relação Quantitativa Estrutura-Atividade , Reprodução/efeitos dos fármacos , Teratogênicos/classificação , Animais , Desenvolvimento Embrionário/efeitos dos fármacos , Feminino , Humanos , Masculino , Camundongos , Valor Preditivo dos Testes , Coelhos , Ratos , Especificidade da Espécie , Terminologia como Assunto , Testes de Toxicidade
2.
Regul Toxicol Pharmacol ; 47(2): 136-55, 2007 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-17175082

RESUMO

This report describes the construction, optimization and validation of a battery of quantitative structure-activity relationship (QSAR) models to predict reproductive and developmental (reprotox) hazards of untested chemicals. These models run with MC4PC software to predict seven general reprotox classes: male and female reproductive toxicity, fetal dysmorphogenesis, functional toxicity, mortality, growth, and newborn behavioral toxicity. The reprotox QSARs incorporate a weight of evidence paradigm using rats, mice, and rabbit reprotox study data and are designed to identify trans-species reprotoxicants. The majority of the reprotox QSARs exhibit good predictive performance properties: high specificity (>80%), low false positives (<20%), significant receiver operating characteristic (ROC) values (>2.00), and high coverage (>80%) in 10% leave-many-out validation experiments. The QSARs are based on 627-2023 chemicals and exhibited a wide applicability domain for FDA regulated organic chemicals for which they were designed. Experiments were also performed using the MC4PC multiple module prediction technology, and ROC statistics, and adjustments to the ratio of active to inactive (A/I ratio) chemicals in training data sets were made to optimize the predictive performance of QSAR models. Results revealed that an A/I ratio of approximately 40% was optimal for MC4PC. We discuss specific recommendations for the application of the reprotox QSAR battery.


Assuntos
Anormalidades Induzidas por Medicamentos , Bases de Dados Factuais , Modelos Teóricos , Relação Quantitativa Estrutura-Atividade , Teratogênicos/classificação , Animais , Simulação por Computador , Desenvolvimento Embrionário/efeitos dos fármacos , Feminino , Humanos , Masculino , Camundongos , Valor Preditivo dos Testes , Coelhos , Ratos , Reprodução/efeitos dos fármacos , Especificidade da Espécie , Terminologia como Assunto , Testes de Toxicidade
3.
Regul Toxicol Pharmacol ; 38(3): 243-59, 2003 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-14623477

RESUMO

MDL QSAR (formerly SciVision QSAR IS) software is one of the several software systems under evaluation by the Informatics and Computational Safety Analysis Staff (ICSAS) of the FDA Center for Drug Evaluation and Research for regulatory and scientific decision support applications. MDL QSAR software contains an integrated set of tools for similarity searching, compound clustering, and modeling molecular structure related parameters that includes 240 electrotopological E-state, connectivity, and other descriptors. These molecular descriptors can be statistically correlated with toxicological or biological endpoints. The goal of this research was to evaluate the feasibility of using MDL QSAR software to develop structure-activity relationship (SAR) models that can be used to predict the carcinogenic potential of pharmaceuticals and organic chemicals. A validation study of 108 compounds that include 86 pharmaceuticals and 22 chemicals that were not present in a control rodent carcinogenicity data set of 1275 compounds demonstrated that MDL QSAR models had excellent coverage (93%) and good sensitivity (72%) and specificity (72%) for rodent carcinogenicity. The software correctly predicted 72% of non-carcinogenic compounds and compounds with carcinogenic findings. E-state descriptors contributed to more than half of the SAR models used to predict carcinogenic activity. We believe that electrotopological E-state descriptors and QSAR IS (MDL QSAR) software are promising new in silico approaches for modeling and predicting rodent carcinogenicity and may have application for other toxicological endpoints.


Assuntos
Carcinógenos , Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos , Previsões , Compostos Orgânicos/toxicidade , Relação Quantitativa Estrutura-Atividade , Algoritmos , Animais , Testes de Carcinogenicidade/métodos , Carcinógenos/toxicidade , Computadores , Sistemas de Gerenciamento de Base de Dados , Aprovação de Drogas , Avaliação Pré-Clínica de Medicamentos , Feminino , Masculino , Metiltiouracila/química , Metiltiouracila/toxicidade , Camundongos , Ratos , Reprodutibilidade dos Testes , Software , Estados Unidos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA